Portugal has been a valued partner of Gavi since 2020, supporting efforts to expand equitable access to vaccines and protect millions of children from vaccine-preventable diseases around the world.
During Gavi’s 2021–2025 strategic period (Gavi 5.0/5.1), Portugal committed €1.6 million (US$ 2 million) to advance Gavi’s mission. This support helped strengthen Gavi’s routine immunisation programmes and contributed to the Gavi COVAX Advance Market Commitment (AMC), which worked to ensure equitable access to COVID-19 vaccines for lower-income countries.
Complementing the Government’s commitment, a coalition of leading Portuguese philanthropies and private sector partners came together during the COVID-19 pandemic to contribute €1.5 million (US$ 2 million) to the COVAX AMC. The consortium included the Fidelidade Group, Manuel António da Mota Foundation, the Ismaili Imamat, Jerónimo Martins Group, Santander Group and Caixa Geral de Depósitos, demonstrating a strong public-private commitment to global health and vaccine equity.
At Gavi’s high-level pledging summit for the 2026–2030 strategic period (Gavi 6.0), the Portuguese government reaffirmed its support for global immunisation with a pledge of €2.5 million (US$ 3 million).
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: